Chronic Myelomonocytic Leukemia Completed Phase 1 Trials for Decitabine (DB01262)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

DBCOND0028572 (Chronic Myelomonocytic Leukemia)Completed1 IdentifierTitlePurposeDrugs
NCT01834248DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaTreatment
NCT00357708Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other DiseasesTreatment